Benefits
Male Sexual Performance / Hardness Score Improvement
In a manufacturer-funded, open-label observational study, men aged 45 to 65 with an Erection Hardness Score of 2 to 3 took EnoSTIM™ 600 mg/day for 28 days; 103 started and 94 completed. Mean Erection Hardness Score rose from 2.7 to 3.3, mean IIEF-5 rose from 15.6 to 17.7, and 74% of participants improved their hardness score. Because there was no placebo group, 74% is a responder rate rather than an effect size: placebo responder rates in erectile-function studies are typically substantial, and without a comparison arm the supplement's own contribution cannot be separated out. The report was not published in a PubMed-indexed journal.
Endothelial Nitric Oxide Synthase (eNOS) Activation
Laboratory work reported by the manufacturer (in vitro and ex vivo) describes activation of endothelial nitric oxide synthase, the enzyme that makes nitric oxide for vasodilation, together with an increase in flow of up to 50% in that laboratory model. No peer-reviewed publication of these experiments was located, and a flow figure obtained in cells and isolated tissue is not a measurement of blood flow in people. Blood flow has not been measured in any published human study of EnoSTIM™.
Antioxidant Activity (Animal and Laboratory Only)
An unpublished animal study reported by the manufacturer describes free-radical scavenging and a 74% fall in an oxidative stress measure. No peer-reviewed publication of this work was located, and no oxidative stress marker has been measured in people taking EnoSTIM™, so the figure should not be read as a human result. Oxidative stress in blood vessels is one of several factors discussed in age-related decline in erectile function.
Healthy Blood Flow Properties
The proposed vascular rationale combines the laboratory eNOS finding with the animal antioxidant finding. Blood flow, flow-mediated dilation and blood pressure have not been measured in any published human study of EnoSTIM™, so this remains a mechanism hypothesis rather than a demonstrated effect on vascular or cardiovascular health.
Saffron Synergy for Sexual Health
Saffron on its own has been tested for sexual function with mixed results. A 4-week trial in 36 men whose sexual difficulty was caused by fluoxetine found improvement in erectile function at 30 mg/day, while the largest trial — 346 men with erectile dysfunction given 30 mg twice daily for 12 weeks — found no benefit on any measure. The manufacturer describes the saffron in a 600 mg serving in relation to a 28 mg/day intake, which is close to the amount used in the small positive trial and about half the amount used in the large null trial. There is no EFSA-authorised health claim for saffron and erection: claims of that kind are unassessed 'on-hold' applications submitted by member states, which EFSA has not evaluated since the European Commission suspended botanical claim assessment in 2010, and which EU courts have held may not be used to advertise a product. Whether the three components act together has not been tested.
Mechanism of action
eNOS Activation → Increased Nitric Oxide → Vasodilation
The proposed mechanism is activation of endothelial nitric oxide synthase, raising nitric oxide production in the vascular endothelium and promoting vasodilation and blood flow. Nitric oxide signalling is central to normal erection, since filling of the corpora cavernosa depends on adequate blood flow. This sequence has been described only in laboratory experiments supplied by the manufacturer and has not been demonstrated in people taking EnoSTIM™. EnoSTIM™ is a food supplement, not a medicine, and has not been compared with, and should not be assumed to work like, prescription erectile dysfunction drugs.
Antioxidant Protection of NO
Nitric oxide is rapidly inactivated by reactive oxygen species. The proposal is that polyphenol antioxidant activity slows that inactivation and preserves nitric oxide availability. Nitric oxide bioavailability has not been measured in people taking EnoSTIM™, so this step is inferred from laboratory work rather than shown. Oxidative stress is one of several factors discussed in age-related changes in sexual function.
Apple + Grape Polyphenols
Combined polyphenol fraction provides antioxidant activity, vascular endothelial support, anti-inflammatory effects. Complementary mechanisms to saffron's serotonergic and circulatory effects.
Saffron Sexual Health Mechanism
Saffron has been studied for effects on sexual function through several proposed pathways, including neurotransmitter modulation and mood effects, and trial results are mixed rather than consistent. Saffron holds no EFSA-authorised health claim for erection or for muscle relaxation. Entries described as 'pending' are on-hold applications that EFSA has never assessed, because the European Commission suspended evaluation of botanical health claims in 2010, leaving more than 2,000 such applications unexamined; an unexamined application is not evidence and not an approval.
Clinical trials
Allaert F, Guillemet D, Schueller R, Herpin F (2021). Open-label observational study of EnoSTIM™ 600 mg/day for 28 days; 103 enrolled, 94 analysed. Funded by Nexira; one author is Nexira's director of scientific development and the other three are affiliated with the evaluation centre that ran the study. Published in Archives in Biomedical Engineering & Biotechnology, a journal not indexed in PubMed.
94 men aged 45 to 65 reporting an Erection Hardness Score of 2 to 3. No placebo or comparison group — every participant received the product.
Mean Erection Hardness Score rose from 2.7 to 3.3 over 28 days and mean IIEF-5 from 15.6 to 17.7; 74% of participants improved their hardness score, and the reported proportion of erections firm enough for penetration rose from 68.0% to 87.7%. All of these are within-group changes in an uncontrolled study, so none of them can be attributed to the supplement rather than to placebo response, expectation or repeated questioning.
In vitro and ex vivo experiments on eNOS activity and vessel flow, reported by the manufacturer. No peer-reviewed publication of this work was located in PubMed.
Cells and isolated tissue. No human participants.
Reported activation of eNOS and an increase in flow of up to 50% in the laboratory model. Laboratory results of this kind do not establish any effect on blood flow or on erectile function in people.